Managing Myeloma
- 2009-09-22 - Study On Myeloma Diagnosis Techniques Favors Newer Imaging Methods
- 2009-09-22 - Study Shows Mozobil Induces Mobilization Of Stem Cells But Not Myeloma Tumor Cells
- 2009-09-21 - FDA Grants Priority Review For VELCADE
- 2009-09-16 - Keryx Biopharmaceuticals Receives Orphan-Drug Designation for KRX-0401 (Perifosine)...
- 2009-09-16 - Amgen to Present Pivotal Data From Four Phase 3 Studies at the ECCO 15 - ESMO 34...
- 2009-09-16 - A preceding monoclonal gammopathy is nearly universal in multiple myeloma-AJHO
- 2009-09-16 - UPDATE 1-Keryx cancer drug gets orphan drug status; shares soar
- 2009-09-15 - Swine Flu Vaccinations Recommended For Multiple Myeloma Patients
- 2009-09-13 - Indo-Americans Laud Actress Lisa Ray for Triumphantly Handling Incurable Cancer
- 2009-09-10 - Mozobil® and Neupogen® Superior to Neupogen® Alone for Harvesting Peripheral Blood Stem Cells
- 2009-09-04 - Combination Actimid And Dexamethasone Regimen Is Promising For Relapsed And Refractory Myeloma Patients
- 2009-09-03 - FDA to Review Supplement Containing Long-Term Survival Data For VELCADE(R) (bortezomib) For Injection
- 2009-09-02 - Patients with multiple myeloma surviving longer than ever
- 2009-09-02 - Study: Higher cancer rates for Hanford workers: Myeloma incidence 3X higher than norm
- 2009-09-02 - Macrophages May Contribute To Survival Of Multiple Myeloma Cells